Integrase, LEDGF/p75 and HIV replication
- PMID: 18264802
- PMCID: PMC3902792
- DOI: 10.1007/s00018-008-7540-5
Integrase, LEDGF/p75 and HIV replication
Abstract
HIV integrates a DNA copy of its genome into a host cell chromosome in each replication cycle. The essential DNA cleaving and joining chemistry of integration is known, but there is less understanding of the process as it occurs in a cell, where two complex and dynamic macromolecular entities are joined: the viral pre-integration complex and chromatin. Among implicated cellular factors, much recent attention has coalesced around LEDGF/p75, a nuclear protein that may act as a chromatin docking factor or receptor for lentiviral pre-integration complexes. LEDGF/p75 tethers HIV integrase to chromatin, protects it from degradation, and strongly influences the genome-wide pattern of HIV integration. Depleting the protein from cells and/or over-expressing its integrase-binding domain blocks viral replication. Current goals are to establish the underlying mechanisms and to determine whether this knowledge can be exploited for antiviral therapy or for targeting lentiviral vector integration in human gene therapy.
Similar articles
-
Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.PLoS Pathog. 2007 Mar;3(3):e47. doi: 10.1371/journal.ppat.0030047. PLoS Pathog. 2007. PMID: 17397262 Free PMC article.
-
Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication.J Biol Chem. 2005 Jul 8;280(27):25517-23. doi: 10.1074/jbc.M501378200. Epub 2005 Apr 25. J Biol Chem. 2005. PMID: 15855167
-
[LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].Yao Xue Xue Bao. 2009 Sep;44(9):953-60. Yao Xue Xue Bao. 2009. PMID: 20055168 Review. Chinese.
-
Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase.Virol J. 2010 Mar 23;7:68. doi: 10.1186/1743-422X-7-68. Virol J. 2010. PMID: 20331877 Free PMC article.
-
The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.Virology. 2013 Jan 5;435(1):102-9. doi: 10.1016/j.virol.2012.09.033. Virology. 2013. PMID: 23217620 Review.
Cited by
-
G-Quadruplex DNA and Other Non-Canonical B-Form DNA Motifs Influence Productive and Latent HIV-1 Integration and Reactivation Potential.Viruses. 2022 Nov 11;14(11):2494. doi: 10.3390/v14112494. Viruses. 2022. PMID: 36423103 Free PMC article.
-
HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.Curr Top Med Chem. 2016;16(10):1154-66. doi: 10.2174/1568026615666150902102143. Curr Top Med Chem. 2016. PMID: 26329615 Free PMC article. Review.
-
Study on suitable analysis method for HIV-1 non-catalytic integrase inhibitor.Virol J. 2021 Jan 13;18(1):17. doi: 10.1186/s12985-020-01476-x. Virol J. 2021. PMID: 33436020 Free PMC article.
-
Development of Protein-Protein Interaction Inhibitors for the Treatment of Infectious Diseases.Adv Protein Chem Struct Biol. 2018;111:197-222. doi: 10.1016/bs.apcsb.2017.07.005. Epub 2017 Aug 24. Adv Protein Chem Struct Biol. 2018. PMID: 29459032 Free PMC article. Review.
-
HIV-1 integrase modulates the interaction of the HIV-1 cellular cofactor LEDGF/p75 with chromatin.Retrovirology. 2011 Apr 21;8:27. doi: 10.1186/1742-4690-8-27. Retrovirology. 2011. PMID: 21510906 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials